Medications for Hypertrophic Cardiomyopathy (HCM)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hypertrophic Cardiomyopathy (HCM).
Found 1 Approved Drug for Hypertrophic Cardiomyopathy (HCM)
Camzyos
Generic Name
Mavacamten
Camzyos
Generic Name
Mavacamten
Form: Capsule
Method of administration: Oral
FDA approval date: April 28, 2022
Classification: Cardiac Myosin Inhibitor
CAMZYOS ® is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMZYOS is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances